MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Understanding patient perceptions of advanced Parkinson’s disease (aPD) treatments

    J. Domingos, R. Pahwa, A. Antonini, I. Malaty, S. Lindvall, F. de Renzis, C. Yan, K. Pantiri, N. Touba, E. Evans, A. Alobaidi, A. Shewale, M. Shah, P. Kukreja, J. Zamudio, K. Chaudhuri (Orpington Kent, United Kingdom)

    Objective: To explore patients’ perceptions of treatment options for aPD and treatment decision considerations. Background: As PD advances, some people with Parkinson’s (PwP) on oral…
  • 2023 International Congress

    Vaccination from Covid-19 in people with Parkinson`s disease

    J. Salimjonov, N. Rashidova, K. Khalimova, R. Matmurodov (Tashkent, Uzbekistan)

    Objective: To assess safety and efficacy of COVID-19 vaccines against SARS-CoV-2 in people with Parkinson’s disease. Background: Different forms of vaccines have been developed to…
  • 2023 International Congress

    The Parkinson’s Disease Composite of Executive-Functioning (PaCEF): A measure for detecting cognitive decline for Parkinson’s disease clinical trials

    C. Young, B. Cholerton, M. Shahid, C. Abdelnour, C. Zabetian, T. Montine, K. Poston (Stanford, USA)

    Objective: To develop a cognitive composite measure that is sensitive to decline in executive functioning for use in Parkinson’s disease (PD) clinical trials. Background: The…
  • 2023 International Congress

    Cardio-respiratory fitness is associated with corticospinal excitability and motor learning in Parkinson’s Disease.

    JC. Cristini, M. Beck, L. Rodrigues, B. De-Las-Heras, S. Steib, A. Dagher, J. Doyon, J. Lundbye-Jensen, M. Roig (Montreal, Canada)

    Objective: To explore associations between cardio-respiratory fitness (VO2peak), cortico-spinal excitability (CSE) and motor learning in people with Parkinson's Disease (PwPD). Background: PwPD show alterations in…
  • 2023 International Congress

    Video-Based Motor Function Assessment by Professional Raters or by Software in Patients with Parkinson’s Disease

    WX. Wu, GJ. Jing, XX. Xu, LZZ. Li, YF. Yang, GXD. Guo (Shanghai, China)

    Objective: To evaluate the consistency of objective movement variables between a computer vision-based movement dysfunction assessment software (MoDAS) and professional raters in video-based motor function…
  • 2023 International Congress

    Amplifying or suppressing subthalamic beta oscillations in real-time in Parkinson’s disease using evoked interference deep brain stimulation (eiDBS): feasibility in the human

    D. Escobar, B. Campbell, S. Mesbah, L. Favi Bocca, J. Liao, R. Rammo, S. Nagel, A. Machado, K. Baker (Cleveland, USA)

    Objective: ​​​​​ ​​To assess the feasibility of continuously amplifying or suppressing subthalamic beta oscillations in real-time in Parkinson's disease (PD) patients using a bidirectional, closed-loop brain…
  • 2023 International Congress

    A Parkinson Shoe with Combined Plantar Pressure and Vibratory Stimulation in Parkinson’s Disease Patients with Freezing of Gait: A Randomized Controlled Trial with Plantar Pressure Analysis

    W. Phuenpathom, P. Panyakaew, P. Vateekul, D. Surangsrirat, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To explore the effect of PD shoes on plantar pressure in PD patients with FOG. Background: Dysfunction of peripheral sensory systems, including decreased cutaneous mechanoreceptors…
  • 2023 International Congress

    GT-02287, a brain-penetrant structurally targeted allosteric regulator for glucocerebrosidase shows evidence of pharmacological efficacy in an animal model of Parkinson’s disease.

    B. Calvo-Flores Guzman, N. Perez-Carmona, A. Garcia-Collazo, E. Cubero, X. Barril, M. Bellotto, J. Taylor (Lugano, Switzerland)

    Objective: To investigate the effect of the structurally targeted allosteric regulator GT-02287 on rotenone-induced neurotoxic effects in a Parkinson’s disease animal model. Background: Mutations in…
  • 2023 International Congress

    Association Between Antiepileptic Drugs and Subsequent Parkinson’s Disease in East London

    Q. Zhang, J. Bestwick, R. Dobson, C. Marshall, A. Noyce (London, United Kingdom)

    Objective: To investigate the association between antiepileptic drugs (AEDs) prescription and subsequent Parkinson’s disease (PD). Background: Recent observational studies have highlighted an association between epilepsy…
  • 2023 International Congress

    Diagnostic accuracy of susceptibility map-weighted MRI for discriminating tremor-dominant Parkinson’s disease and essential tremor

    MK. Yoon, S. Jo, S. Lee, J. Lee, CH. Suh, SJ. Chung (Seoul, Republic of Korea)

    Objective: We investigated the diagnostic accuracy of nigrosome using susceptibility map-weighted imaging (SMwI) in distinguishing tremor-dominant Parkinson's disease (PD) and essential tremor (ET). Background: Tremor is…
  • « Previous Page
  • 1
  • …
  • 262
  • 263
  • 264
  • 265
  • 266
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley